Heart Disease and Air Pollution: A Cardiologist's Perspective

In the autumn of 1948, a thick yellow smog settled over the mill town of Donora, Pennsylvania, trapped by a temperature inversion in the Monongahela River valley. Emissions from the zinc smelter and steel mill accumulated for four days. By the time rain finally lifted the smog, 20 people were dead and nearly half of the town's 14,000 residents had fallen ill. The majority of the deaths were cardiovascular.

Donora 1948 was a natural experiment that predated epidemiological method — nobody had thought to instrument the town or document exposure levels. But the pattern it revealed — acute pollution events killing people with underlying cardiovascular disease — established a template that subsequent research has confirmed and refined over seven decades. Air pollution doesn't just fill lungs with particles. It reaches the heart.

The American Heart Association's 2010 scientific statement — since updated — concluded that PM2.5 is causally related to cardiovascular disease and mortality. The word "causally" was chosen carefully by a committee that reviewed thousands of studies. It means that the evidence meets the highest standard for inference in epidemiology: not just correlation, not merely association, but a judgment that air pollution is in the causal chain leading to cardiovascular events and death.

The cardiovascular effects of PM2.5 operate through multiple biological pathways that are now documented from the molecular level upward.

The endothelial dysfunction signal — the earliest marker Endothelial cells line blood vessel walls and regulate vascular tone, blood clotting, and inflammation. Their ability to dilate vessels in response to demand — flow-mediated dilation — is one of the most sensitive measures of early cardiovascular disease. Studies using forearm blood flow measurements have found measurable reductions in flow-mediated dilation in healthy adults on high-PM2.5 days, reverting when pollution levels drop.

This is the earliest functional marker of PM2.5's cardiovascular effect — and it occurs in healthy people, not just those with pre-existing disease. It precedes inflammation, precedes elevated biomarkers, and precedes any symptoms. It's the system warning light, flashing before anything breaks.

From endothelium to plaque instability In people with existing atherosclerotic plaques — the fatty deposits that narrow coronary arteries — PM2.5-induced inflammation and oxidative stress can trigger plaque rupture. Most heart attacks are not caused by arteries slowly closing; they're caused by vulnerable plaques suddenly rupturing, triggering a clot that blocks blood flow. The evidence that PM2.5 destabilises plaques through inflammatory pathways helps explain why cardiac emergency room admissions spike within 24–48 hours of high-pollution events.

Arrhythmia Air pollution affects cardiac electrical activity. Reductions in heart rate variability — a marker of autonomic nervous system dysfunction — have been measured on high-pollution days in multiple populations. Air pollution exposure is associated with increased rates of atrial fibrillation hospitalisation, and with sudden cardiac death in individuals with implantable defibrillators who experienced inappropriate shocks on high-pollution days.

The cardiovascular data divides into two distinct bodies of evidence with different implications: short-term exposure effects and long-term exposure effects.

Short-term: the acute cardiac event signal Time-series analyses — studies that track daily variation in air pollution alongside daily hospital admissions and mortality — find that cardiovascular events cluster after high-pollution days. A comprehensive analysis published in Circulation examining data from 204 cities found that each 10 µg/m³ increase in PM2.5 was associated with a 0.4–1.0% increase in cardiovascular mortality in the following days.

These short-term effects represent pollution triggering events in people who already have significant underlying cardiovascular disease — people who might have had a cardiac event anyway, but had it sooner, and sometimes fatally, because of a pollution spike.

Long-term: the structural risk accumulation The American Cancer Society Cancer Prevention Study II — following over 500,000 adults for 16 years — found that each 10 µg/m³ increment in long-term PM2.5 exposure was associated with a 12% increase in cardiovascular mortality and a 9% increase in ischaemic heart disease mortality. These effects represent decades of exposure slowly building atherosclerosis, impairing endothelial function, and accumulating the arterial damage that makes acute events more likely.

The distinction matters clinically: short-term effects suggest air quality management on bad days; long-term effects suggest address-level lifetime exposure is a cardiovascular risk factor comparable to moderate hypertension or dyslipidaemia — one that should be assessed and tracked alongside traditional risk factors.

For patients and clinicians managing cardiovascular risk, the evidence on air pollution suggests two levels of intervention: immediate risk management on high-pollution days, and longer-term exposure history assessment as part of cardiovascular risk profiling.

Day-to-day cardiovascular protection: For people with established cardiovascular disease, or significant cardiovascular risk factors, the threshold for protective behaviour on high-pollution days should be lower than for the general population: • AQI Orange (101–150): reduce outdoor exertion; avoid outdoor exercise near traffic • AQI Red (151–200): limit all outdoor activity; run indoor filtration; keep windows closed • Medication adherence is particularly important during high-pollution periods — this is not the week to run out of antihypertensives or antiplatelets

Air quality as a vital sign PollutionProfile's Air Quality feature gives you your local AQI every morning. For people managing cardiovascular disease, this daily check is as clinically relevant as checking blood pressure — both are modifiable inputs to daily cardiovascular risk.

The exposure history conversation with a cardiologist Your lifetime PM2.5 exposure history from PollutionProfile's Historical Exposure Recorder is cardiovascular risk information — as relevant to your cardiologist as your lipid history or blood pressure record. The conversation to initiate: "I've been tracking my air quality exposure history. Is this something worth factoring into my cardiovascular risk assessment and management plan?"

This is a conversation most cardiologists haven't been asked to have — but with the AHA's causal statement on PM2.5 as background, it's a conversation the evidence fully supports.